Tablets Ekslyuton - instruction , application reviews


1. release form and composition

2. Pharmacological action Ekslyutona

3. Application Ekslyutona on

instructions 4. Side effects Ekslyutona

5. overdose of pills Ekslyuton

6. Contraindications Ekslyutona

7. drug interactions Ekslyutona

Ekslyuton relates to steroid hormonal drugs.It does not contain estrogen and for oral contraception.In the role of an active drug substance acts linestrenol.

release form and composition

Ekslyuton issued by the manufacturer in a single dosage form - tablets.Each tablet contains 500 mg linestrenola.Auxiliary components: amylopectin, magnesium stearate, potato starch, lactose monohydrate.The product is sold at 28 or 84 tablets in a package.

Pharmacological action Ekslyutona

Ekslyutona The structure does not include estrogen.The active ingredient of this drug is the progestogenic component - linestrenol.When ingested, it is transformed into a woman a biologically active norethisterone, which binds to the progesterone r

eceptor in the muscular wall of the uterus.

contraceptive pills Ekslyuton effect is achieved by increasing the viscosity of cervical mucus that is blocking the promotion of sperm and decreases the sensitivity of the uterine lining to mature female reproductive cell, disrupting the wavelike contractions of the walls of the fallopian tubes.

According to reviews on Ekslyutone, the systematic taking the drug for most women stops ovulating, as evidenced by an increase in progesterone level and a lack of maximizing luteinizing hormone in the middle of the cycle.Thus Ekslyuton not affect lipid metabolism, carbohydrate and hemostasis in women.

Application Ekslyutona on

Ekslyuton instructions is intended solely for contraception.It should be taken every day at the same time for 28 days.The maximum possible deviation from the desired reception time - 3 h.

If the delay in taking the drug less than three hours, the missed tablet should be taken as soon as possible, and should be taken at the usual time.If the delay is more than three hours, in this case, in addition to resort to a barrier method of contraception for the next 7 days.If the drug was missed in the first week of the course, and a week before skipping pills or later the woman had sexual intercourse, in this case, the possible pregnancy.

Reception Ekslyuton tablets should be started at the beginning of the menstrual cycle, without making breaks.That is, each subsequent packaging of the drug should begin to take immediately after the previous one.

the presence of gastrointestinal disorders, tablets may be incomplete absorption.In this case, it is recommended to practice additional contraceptive measures.

Side effects Ekslyutona

Ekslyutona When taken during the first cycle of use of the drug in 50% of women develop such adverse reactions as mood swings, nausea, headaches, irregular menstruation and painful sensations in the breasts.These phenomena are subsequently reduced closer to the 12-th cycle.

In their comments on Ekslyutone some patients complain of a number of other side effects of the drug:

  • CNS depression, libido changes, migraine;
  • on the part of the genitourinary system: changes in vaginal secretion;
  • on the part of the digestive tract: abdominal pain, vomiting, constipation or diarrhea;
  • by the mammary glands: swollen glands, increased sensitivity, galactorrhea;
  • on the part of the organ of vision: hypersensitivity to contact lenses;
  • with the skin: erythema nodosum, rash, erythema multiforme;
  • other effects: changes in body weight, urinary retention, allergic reactions.

overdose of pills Ekslyuton

The instructions to Ekslyutonu not reported any serious adverse reactions of the body as a result of an overdose.Since the drug has a sufficiently low toxicity, even while taking a few tablets is not expected occurrence of severe toxic symptoms.According to the reviews of Ekslyutone, drug overdose may be accompanied by the following symptoms: a slight discharge of blood from the vagina, nausea or vomiting.Further treatment is symptomatic.

Contraindications Ekslyutona

contraceptives, which include only prostagen, should not be prescribed if a woman has any of the conditions listed below:

  • installed or possible pregnancy;
  • cholestatic jaundice;
  • severe liver disease or a history of its existence;
  • progestagenzavisimye tumor;
  • porphyria;
  • vaginal bleeding of unknown etiology;
  • venous thromboembolism;
  • otosclerosis;
  • herpes gestationis in history;
  • hypersensitivity to the active substance Ekslyuton tablets.

The instructions to Ekslyutonu also noted that the drug should be taken with caution to patients with the following illnesses:

  • high blood pressure;
  • diabetes;
  • diseases associated with impaired renal function;
  • increased tendency to thrombosis;
  • heart failure;
  • predisposition to disease from the blood vessels and the heart;
  • migraines and seizures in the present or in history.

Drug Interactions Ekslyutona

Ekslyuton able to interact with drugs that induce microsomal liver enzymes, which ultimately could lead to increased clearance of sex hormones.

established Ekslyutona interaction with carbamazepine, Rifamiitsinom, topiramate, griseofulvin, primidone, ritonavir, felbamate, rifabutin, Okskarbazeiinom, barbiturates, hydantoins and Drug Administration, which is present in the composition of St. John's wort.Women using any of these drugs should be in addition to tablets Ekslyuton temporarily resort to barrier methods of contraception.Barrier method should be used not only during the concomitant use of these drugs, but 28 days after cessation of use.

Ekslyuton tablets Absorption is reduced by concomitant use of activated carbon, which may affect the contraceptive efficacy.


Product description posted on this page is a supplement and a simplified version of the official version of the annotations to the drug.The information is provided for informational purposes only and is not a guide to self-medication.Before using the product you should consult with a specialist and to get acquainted with the instructions approved by the manufacturer.

Latest Blog Post

Ethambutol - instruction , application reviews
August 12, 2017

Contents: 1. active substance 2. Product form 3. Composition 4. Indications 5. Contraindications 6. dosage and Adminis...

Efizol - instruction , application reviews
August 12, 2017

Contents: 1. active substance 2. Product form 3. Indications 4. Contraindications 5. Dosage and Administration 6. Side...

Estrofem - instruction , application reviews
August 12, 2017

Contents: 1. Pharmacological action 2. Indications Estrofema 3. Contraindications 4. Instructions for use Estrofema 5. Si...